RxElite, Inc.

RXEI · OTC
Analyze with AI
12/31/2007
9/30/2006
9/30/2005
9/30/2004
Operating Activities
Net Income-$17,165$94-$36
Dep. & Amort.$437$14$7
Deferred Tax$0$0$0
Stock-Based Comp.$0$0$0
Change in WC-$2,992-$36$42
Other Non-Cash$6,354$0$0
Operating Cash Flow-$13,366$72$13
Investing Activities
PP&E Inv.-$1,847-$12-$45
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$0$0$0
Investing Cash Flow-$1,847-$12-$45
Financing Activities
Debt Repay.$9,574$0$0
Stock Issued$15,714$1$0
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.-$2,364$0$0
Financing Cash Flow$22,924$1$0
Forex Effect$0$0$0
Net Chg. in Cash$7,710$60-$31
Supplemental Information
Beg. Cash$2,403$3$34
End Cash$10,114$63$3
Free Cash Flow-$15,213$60-$31